Top accelerator startups

14,448 startups · 29 programs

Diapin Therapeutics

Novel Therapies for Cardiovascular and Metabolic Diseases

1signal of 100 · rising 1
  • went through Plug and PlayProgram · this site+1

A sum of public facts, not a judgement and not investment advice.

Competitors

Adjacent

Also from Plug and Play

All of Plug and Play

Programs

Programs Diapin Therapeutics went through
ProgramCohortSource
Plug and PlayNot statedPlug and Play Page

About Diapin Therapeutics

Diapin Therapeutics is a health and lifetech company focused on developing novel therapies for cardiovascular and metabolic diseases. The company’s mission centers on advancing innovative treatments to address critical unmet medical needs in these areas. Its key products include DT678, a best-in-class anti-platelet therapy designed to prevent stroke and heart attacks in cardiovascular disease patients, and DT109, a peptide targeting metabolic conditions such as non-alcoholic fatty liver disease (NAFLD), metabolic-associated steatohepatitis (MASH), and atherosclerosis. Both assets originated from academic research and are progressing through clinical and preclinical development stages. Diapin Therapeutics contributes to medical innovation by translating cutting-edge scientific discoveries into promising therapeutic candidates aimed at improving patient outcomes in complex chronic diseases.

Category
Other
Location
United States
Checked
7h ago

Diapin Therapeutics: questions

Which accelerators did Diapin Therapeutics go through?

Diapin Therapeutics is listed by Plug and Play.

Where is Diapin Therapeutics based?

Diapin Therapeutics lists United States as its location on Plug and Play's page.